Supernus Pharmaceuticals, Inc. Shares Outstanding 2010–2025
Supernus Pharmaceuticals, Inc. reported 57.5M of shares outstanding for fiscal 2025. That was 3.1% higher than fiscal 2024. Compared with fiscal 2020, the change was +8.7%. A rising share count can dilute per-share ownership; the filings should be checked for issuance and stock-compensation details.
| Fiscal year | Shares Outstanding | Change (YoY) |
|---|---|---|
| FY 2025 | 57.5M | +3.1% |
| FY 2024 | 55.7M | +1.9% |
| FY 2023 | 54.7M | +0.9% |
| FY 2022 | 54.3M | +1.9% |
| FY 2021 | 53.3M | +0.7% |
| FY 2020 | 52.9M | +0.6% |
| FY 2019 | 52.5M | +0.4% |
| FY 2018 | 52.3M | +2.0% |
| FY 2017 | 51.3M | +2.7% |
| FY 2016 | 50.0M | +2.0% |
| FY 2015 | 49.0M | +14.0% |
| FY 2014 | 43.0M | +7.5% |
| FY 2013 | 40.0M | +30.6% |
| FY 2012 | 30.6M | +1742.1% |
| FY 2011 | 1.7M | — |
| FY 2010 | 0.0M | — |
Source: Supernus Pharmaceuticals, Inc. SEC filings — balance sheet (10-K), split-adjusted. Computed deterministically; refreshed nightly (last updated August 2, 2026). Open SUPN 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Supernus Pharmaceuticals, Inc. reported 57.5M of shares outstanding for fiscal 2025. That was 3.1% higher than fiscal 2024. Compared with fiscal 2020, the change was +8.7%. A rising share count can dilute per-share ownership; the filings should be checked for issuance and stock-compensation details. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Supernus Pharmaceuticals, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeSupernus Pharmaceuticals, Inc. — frequently asked questions
What is Supernus Pharmaceuticals, Inc.'s shares outstanding?
Supernus Pharmaceuticals, Inc. (SUPN) reported shares outstanding of 57.5M for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from Supernus Pharmaceuticals, Inc.'s official SEC filings (balance sheet (10-K), split-adjusted), refreshed nightly. Not investment advice.
More SUPN financial history
Full SUPN fundamentals page → · Analyze shares outstanding with a free tool → · Research guide & leaders → · All 1,500+ companies →